CXCR4 antagonist 3
CXCR4 antagonist 3 (compound 12a) is a potent antagonist of CXCR4 with an IC50 of 11 nM. CXCR4 antagonist 3 is a congener of TIQ15. CXCR4 antagonist 3 demonstrates the best overall properties including CXCR4 antagonism, CYP 2D6 inhibition, metabolic stability, and permeability. CXCR4 antagonist 3 has the potential for the research of human immunodeficiency virus[1].
Product Specifications
CAS Number
2761009-43-0
UNSPSC
12352005
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cxcr4-antagonist-3.html
Solubility
10 mM in DMSO
Smiles
NCCCCN([C@@H]1C2=NC=CC=C2CCC1)C[C@@H]3NCC4=C(C3)N=CC=C4
Molecular Formula
C22H31N5
Molecular Weight
365.52
References & Citations
[1]Jecs E, et al. Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles. J Med Chem. 2022;65 (5) :4058-4084.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6234933-01 0.1 mL
RCE1 (CAAX Prenyl Protease 2, Prenyl Protein-specific Endoprotease 2, Farnesylated Proteins-converting Enzyme 2, FACE-2, RCE1 Homolog, hRCE1, FACE2, RCE1A, RCE1B) (MaxLight 750)
Sign In for Pricing
View Details MBS6234933-02 5x 0.1 mL
RCE1 (CAAX Prenyl Protease 2, Prenyl Protein-specific Endoprotease 2, Farnesylated Proteins-converting Enzyme 2, FACE-2, RCE1 Homolog, hRCE1, FACE2, RCE1A, RCE1B) (MaxLight 750)
Sign In for Pricing
View Details MBS7083340 Inquire
Recombinant Phytophthora infestans Phospholipase D (PLD), partial
Sign In for Pricing
View Details 
